scispace - formally typeset
G

Garry P. Nolan

Researcher at Stanford University

Publications -  519
Citations -  54521

Garry P. Nolan is an academic researcher from Stanford University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 104, co-authored 474 publications receiving 46025 citations. Previous affiliations of Garry P. Nolan include Massachusetts Institute of Technology & New York University.

Papers
More filters
Journal ArticleDOI

NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I

TL;DR: It is shown that the binding of Rel p50 and p52 homodimers at sites within the transcriptional initiation region of HIV-1 provides for their ability to interact with other proteins that bind the initiator, suggesting roles for Rel proteins in early events determining transcriptional control.
Journal ArticleDOI

Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity.

Nathan W. Zammit, +76 more
- 18 Sep 2019 - 
TL;DR: Genetic analyses of anatomically modern humans, extinct Denisovan hominins and mice revealed a TNFAIP3 allelic series with alterations in the encoded immune response inhibitor A20, which lower A20 activity and increase autoinflammatory responses.
Patent

Methods and compositions for detecting the activation state of multiple proteins in single cells

TL;DR: In this paper, the authors provide methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry, which can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state.
Journal ArticleDOI

Virtual and augmented reality for biomedical applications

TL;DR: In this article, the authors provide a perspective on XR in current biomedical applications and demonstrate case studies using cell biology concepts, multiplexed proteomics images, surgical data for heart operations, and cardiac 3D models.
Journal ArticleDOI

Retroviral Delivery of Peptide Modulators of Cellular Functions

TL;DR: The ability to express protein microdomains can be a powerful means to subtly perturb cellular physiology in manners that reveal new paths for therapeutic intervention, and it is believed that such approaches might allow for new forms of gene therapy to become available.